ED50 and ED95 of Intrathecal Hyperbaric Bupivacaine With Fentanyl for Transurethral Prostatectomy in Elderly Patients
NCT ID: NCT03704441
Last Updated: 2022-03-21
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
13 participants
INTERVENTIONAL
2018-11-01
2020-09-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Effects of Intrathecal Dexmedetomidine on Spinal Anesthesia Using Diluted Low-Dose Bupivacaine for Transurethral Resection of Prostate in Elderly
NCT01342562
Comparison of Intrathecal Fentanyl or Sufentanil in 1 mg Bupivacaine Spinal Anesthesia for TURP in Elderly Patients
NCT01608334
Low Dose Bupivacaine Spinal for Trans Uretral Prostatectomy.
NCT01861041
Comparison of Hemodynamic Effect Between the Spinal Anesthesia and Saddle Block Using Levobupivacaine During Transurethral Resection of the Prostate in Cardiac Elderly Patients
NCT06014957
Effect of Two Different Doses of Intrathecal Dexmedetomidine as Adjuvant in Elderly Patients Undergoing HoLEP
NCT05351489
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
bupivacaine 6mg
bupivacaine 6mg
Bupivacaine
bupivacaine dose
bupivacaine 7mg
bupivacaine 7mg
Bupivacaine
bupivacaine dose
bupivacaine 8mg
bupivacaine 8mg
Bupivacaine
bupivacaine dose
bupivacaine 9mg
bupivacaine 9mg
Bupivacaine
bupivacaine dose
bupivacaine 10mg
bupivacaine 10mg
Bupivacaine
bupivacaine dose
bupivacaine 11mg
bupivacaine 11mg
Bupivacaine
bupivacaine dose
bupivacaine 12mg
bupivacaine 12mg
Bupivacaine
bupivacaine dose
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Bupivacaine
bupivacaine dose
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Male between 65 and 100
* The American Society of Anesthesiologists physical status class 1 or 2
Exclusion Criteria
* Patients with infectious disease
* Patients with a drug allergy
* Patients under 50kg or over 100kg
* In case of switching to general anesthesia
65 Years
100 Years
MALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hallym University Kangnam Sacred Heart Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Eun Mi Choi, MD
Role: STUDY_DIRECTOR
Hallym University Kangnam Sacred Heart Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Kangnam sacred heart hospital
Seoul, Yeongdeungpo-gu, South Korea
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
KangnamAnes
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.